tiprankstipranks
COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
US Market

COSCIENS Biopharma (CSCI) Financial Statements

Compare
907 Followers

COSCIENS Biopharma Financial Overview

COSCIENS Biopharma's market cap is currently $8.56M. The company's EPS TTM is $-26.087; its P/E ratio is ―; COSCIENS Biopharma is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 4.50M$ 5.64M$ -90.00K$ 1.69M$ -69.00K
Operating Income$ -17.73M$ -15.03M$ -13.93M$ -5.71M$ -9.73M
EBITDA$ -17.99M$ -26.05M$ -7.96M$ -6.28M$ -5.92M
Net Income$ -16.55M$ -24.48M$ -16.85M$ -6.91M$ -7.03M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 37.02M$ 56.03M$ 80.10M$ 37.01M$ 19.98M
Total Debt$ 279.00K$ 179.00K$ 161.00K$ 184.00K$ 903.00K
Net Debt$ -33.74M$ -50.43M$ -174.00K$ -154.00K$ 539.00K
Total Liabilities$ 18.82M$ 20.25M$ 27.12M$ 23.79M$ 22.44M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -17.14M$ -14.53M$ -9.22M$ -4.12M$ -10.72M
Operating Cash Flow$ -17.12M$ -14.52M$ -8.58M$ -4.13M$ -10.72M
Investing Cash Flow
Financing Cash Flow
Currency in USD

COSCIENS Biopharma Earnings and Revenue History

COSCIENS Biopharma Debt to Assets

COSCIENS Biopharma Cash Flow

COSCIENS Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis